Staying current with emerging research is essential for delivering evidence-based allergy and rhinology care. The latest AAOA Journal Club session provides a valuable review of recent literature impacting the diagnosis and management of allergic and inflammatory conditions encountered in otolaryngology…
Access to Affordable Life-Saving Medications
EO: Sec. 7. Access to Affordable Life-Saving Medications. Within 90 days of the date of this order, as appropriate and consistent with applicable law, the Secretary shall take action to ensure future grants available under section 330(e) of the Public Health Service Act, as amended, 42 U.S.C. 254b(e), are conditioned upon health centers establishing practices to make insulin and injectable epinephrine available at or below the discounted price paid by the health center grantee or sub-grantee under the 340B Prescription Drug Program (plus a minimal administration fee) to individuals with low incomes, as determined by the Secretary, who:
(a) have a high cost-sharing requirement for either insulin or injectable epinephrine;
(b) have a high unmet deductible; or
(c) have no healthcare insurance.




